top of page

CYTORA is a clinical stage stem cell company developing a new class of

medicines  based on a novel and transformative  patented
stem cell technology derived from unique

human Oral Mucosa Stem Cells (hOMSC)

scientist-pipetting-stem-cells-in-tubes-2022-01-19-00-27-44-utc (1).jpg


human Oral Mucosa Stem Cells

A unique phenomenon occurs in the mouth. 

Rapid Wound Healing compared to
other tissues.

No scars!  - Full regeneration.

Regeneration is not affected by age!

This pattern of wound healing is negligibly affected by diabetes. 

2 weeks later


Novel and Unique

Cytora’s patented and transformative platform stem cell technology is based on the discovery of a novel and unique stem cell population in the oral mucosa termed “human Oral Mucosa Stem Cells (hOMSC)”.


Under Clinical Development

Diabetic Wound Healing - Incurable Diabetic Foot Ulcer (IDFU) - Clinical Studies in Progress.

Central & Autonomic Nervous System - Multiple System Atrophy (MSA) - Clinical Studies in progress.

Our Team_orange banner.jpg
Team pic.png

Our Team

Highly qualified, deeply scientific team with years of research, patents and industry experience in the fields of biotechnology and stem cell therapy.

World renowned, expert scientific advisory board - Leading clinical experts in their respective fields.

bottom of page